Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma. 2015

Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
a Department of Radiotherapy ; King George's Medical University ; Lucknow , India.

This study compared the efficacy and toxicity of Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil (5-FU) in patients of recurrent squamous cell carcinoma of head and neck (SCCHN) treated with palliative intent. Patients with recurrent SCCHN not amenable to curative treatment were randomly assigned to Gefitinib, Methotrexate or Methotrexate plus 5-FU arm. The primary end point was overall survival. Secondary end points of interest were objective response rate, toxicity and quality of life. Total 117 patients were analyzed. Median overall survival and objective response rates were 8.8 months, 7.8 months and 8.1 months and 7.7%, 5.0% and 7.9% in Gefitinib, Methotrexate and Methotrexate plus 5-FU arms respectively with no statistically significant difference between 3 arms. Gefitinib had different toxicity profile compared with other arms. Majority of toxicities were Grade 1 or Grade 2. Gefitinib had significant improvement in quality of life during initial months over Methotrexate. There was no suggestion that Gefitinib significantly prolonged overall survival compared with Methotrexate and Methotrexate plus 5-FU. However, improved Quality of Life with manageable toxicities was observed.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
September 1983, Cancer,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
January 2013, Asian Pacific journal of cancer prevention : APJCP,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
December 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
June 1983, Seminars in oncology,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
August 1992, The Laryngoscope,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
October 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
May 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
December 1987, Cancer,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
March 2006, British journal of cancer,
Vandana Singh Kushwaha, and Seema Gupta, and Nuzhat Husain, and Huma Khan, and M P S Negi, and Naseem Jamal, and Ashim Ghatak
May 2000, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!